Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13117-35-6

Post Buying Request

13117-35-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13117-35-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13117-35-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,1 and 7 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13117-35:
(7*1)+(6*3)+(5*1)+(4*1)+(3*7)+(2*3)+(1*5)=66
66 % 10 = 6
So 13117-35-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H18N2/c1-15(2)9-5-6-11-10-14-13-8-4-3-7-12(11)13/h3-4,7-8,10,14H,5-6,9H2,1-2H3

13117-35-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1H-indol-3-yl)-N,N-dimethylpropan-1-amine

1.2 Other means of identification

Product number -
Other names N-Dimethylhomotryptamin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13117-35-6 SDS

13117-35-6Downstream Products

13117-35-6Relevant articles and documents

Indole derivatives and its application on the medicament

-

Paragraph 0381; 0391-0394, (2019/03/28)

The invention provides indole derivatives or stereisomers, tautomers, nitrogen oxides, solvate, metabolic products, pharmaceutically acceptable salts or prodrugs thereof for treating the alzheimer disease. The invention further discloses a pharmaceutical composition containing the compounds and a method of using the compounds or the pharmaceutical composition thereof to treat the alzheimer disease.

Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs)

Schmitz, William D.,Denhart, Derek J.,Brenner, Allison B.,Ditta, Jonathan L.,Mattson, Ronald J.,Mattson, Gail K.,Molski, Thaddeus F.,Macor, John E.

, p. 1619 - 1621 (2007/10/03)

A series of N,N-dimethylhomotryptamines was prepared and their binding affinities at the serotonin transporter (SERT) were determined. Compounds possessing an electron withdrawing substituent at the C5-position of the indole nucleus were found to be poten

Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase

Guan, Huiping,Laird, A. Douglas,Blake, Robert A.,Tang, Cho,Liang, Chris

, p. 187 - 190 (2007/10/03)

A novel series of substituted 3-[3-(aminopropyl)-4,5,6,7-tetrahydro-1H- indol-2-ylmethylene]-1,3-dihydro-indole-2-ones was discovered as potent inhibitors of the non-receptor tyrosine kinase Src and Yes. A structure-activity relationship was developed in order to optimize their potency and selectivity. Syntheses of these compounds are also described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13117-35-6